ICON: Food allergy
A Wesley Burks, Mimi Tang, Scott Sicherer, Antonella Muraro, Philippe A Eigenmann, Motohiro Ebisawa, Alessandro Fiocchi, Wen Chiang, Kirsten Beyer, Robert Wood, Jonathan Hourihane, Stacie M Jones, Gideon Lack, Hugh A Sampson
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | MOSBY-ELSEVIER | Published : 2012
Food allergies can result in life-threatening reactions and diminish quality of life. In the last several decades, the prevalence of food allergies has increased in several regions throughout the world. Although more than 170 foods have been identified as being potentially allergenic, a minority of these foods cause the majority of reactions, and common food allergens vary between geographic regions. Treatment of food allergy involves strict avoidance of the trigger food. Medications manage symptoms of disease, but currently, there is no cure for food allergy. In light of the increasing burden of allergic diseases, the American Academy of Allergy, Asthma & Immunology; European Academy of All..View full abstract
Awarded by Medical Research Council
Awarded by National Institute for Health Research
A. W. Burks is a minority stockholder in Allertein and Mast Cell, Inc; is on an advisory board or expert panel for Dannon Co Probiotics and Nutricia; has consulted for Exploramed Development, LLC, Intelliject, McNeil Nutritionals, Merck & Co, Novartis, Pfizer, Portola Pharmaceuticals, and Schering-Plough; has received research support from the National Institutes of Health (NIH), the Food Allergy and Anaphylaxis Network (FAAN), the Food Allergy Initiative (FAI), the National Peanut Board, SHS, and the Wallace Research Foundation; has provided legal consultation or expert witness testimony on the topic of food allergy; and is on the medical board of directors of FAAN. M. Tang has received study products from Nestle Research Institute; has been an invited speaker on food allergy and anaphylaxis for Link Pharmaceuticals, Alphapharm, Nutricia, Wyeth, and Nestle Nutrition Institute; and has served on advisory boards for Nestle Nutrition Institute and Nutricia. S. Sicherer has consulted for, and received grants from FAI; has served as an advisor to FAAN; and has received grants from the National Institute of Allergy and Infectious Diseases (NIAID). P. A. Eigenmann is an ex-committee member of the European Academy of Allergy and Clinical Immunology. A. Fiocchi has received research support from Allegria Onlus. K. Beyer has received consulting fees and honoraria from Danone and Novartis; has received honoraria from Phadia, Infectopharm, Hipp, UCB, and Meda Pharma; and has received research support from the German Research Foundation, the European Union, Danone, and the Foundation for the Treatment of Peanut Allergy. R. Wood has consulted for the Asthma and Allergy Foundation of America, has received research support from the NIH, and is on the medical advisory board for FAAN. J. O. Hourihane has received research support from the Children's Research Foundation (Ireland), Danone, the Food Standards Agency (United Kingdom), and Stallergenes; in addition, his employer, University College Cork, holds a patent on challenge outcome predictor software. S. M. Jones has received research support from the NIH/NIAID, the National Peanut Board, and FAAN; in addition, she serves on an advisory board for FAAN. G. Lack has received sponsorship from Sodilac, Novartis, the Spanish Society of Allergy and Clinical Immunology, Danone Nutricia, and Nestle; has received research support from the Immune Tolerance Network/NIH, National Peanut Board, Food Standards Agency, Medical Research Council, FAI, Action Medical Research, ALK Abello, and Guy's & St Thomas' Charity; is a voluntary scientific advisor for the Anaphylaxis Campaign and National Peanut Board; and is scientific advisor for DBV Technologies. H. A. Sampson has consulted for Allertein Therapeutics, LLC; has served on advisory boards for ImmusanT and Novartis; has received research support from the NIH/NIAID and FAI; has served as a consultant or advisor to FAI, FAAN, and the University of Nebraska-FARRP; and is a part-owner of Herb Springs, LLC. The rest of the authors declare that they have no relevant conflicts of interest.